tiprankstipranks
Biolase (DE:BTH)
FRANKFURT:BTH

Biolase (BTH) Financial Statements

0 Followers

Biolase Financial Overview

Biolase's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Biolase is scheduled to report earnings on ―, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue$ 10.47M$ 14.05M$ 12.01M$ 12.23M$ 10.17M
Gross Profit$ 3.34M$ 3.60M$ 2.44M$ 5.14M$ 4.73M
EBIT$ -5.27M$ -8.31M$ -7.98M$ -5.16M$ -4.33M
EBITDA$ -5.37M$ -8.01M$ -7.86M$ -5.03M$ -4.21M
Net Income Common Stockholders$ -5.85M$ -9.43M$ -8.39M$ -5.61M$ -4.99M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 6.50M$ 4.18M$ 9.96M$ 19.55M$ 21.61M
Total Assets$ 41.94M$ 38.19M$ 42.87M$ 50.85M$ 50.24M
Total Debt$ 15.33M$ 15.05M$ 14.84M$ 14.91M$ 15.86M
Net Debt$ 8.83M$ 10.87M$ 4.88M$ -4.64M$ -5.75M
Total Liabilities$ 33.79M$ 33.30M$ 29.01M$ 29.24M$ 29.64M
Stockholders Equity$ 8.16M$ 4.89M$ 13.86M$ 21.61M$ 20.60M
Cash Flow-
Free Cash Flow$ -6.25M$ -6.07M$ -9.22M$ -6.89M$ -8.32M
Operating Cash Flow$ -5.66M$ -5.60M$ -6.55M$ -6.61M$ -8.02M
Investing Cash Flow$ -587.00K$ -444.00K$ -2.68M$ -274.00K$ -304.00K
Financing Cash Flow$ 8.51M$ -32.00K$ -214.00K$ 4.85M$ 0.00
Currency in USD

Biolase Earnings and Revenue History

Biolase Debt to Assets

Biolase Cash Flow

Biolase Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis